Annual BUX forecasts now more pessimistic
Lock-up period expires
Stock of own shares nears 1 mn
Richter product launched in Japan by partner
OTP also sets new record price
Mol, OTP ride the bull
Richter was the flavour of the month
Management turn more upbeat
Revenue rose 28.2% y/y
Profit expected to jump from low base
Not just in the U.S. but in Europe as well
For RVVC drug VT-1161
U.S. company informs Richter about decrease on Monday.
Mitsubishi Tanabe will distribute cariprazine in Thailand and Singapore.
With a 10% decrease in Russia and 20% in China
Revenue rose 8.5% to HUF 120 billion.
Analysts forecast 30% lower net profit.
Hikma will supply the antipsychotic drug in the MENA region.
Monthly survey results published.